On March 8, 2025, Bangalore became the hub of pioneering discussions as the Zydus Lifesciences presents ET Edge Onco Frontiers Summit 2025 powered by MOC India and co-powered by Eris Lifesciences in association with Association of Healthcare Providers (India) convened leading oncologists, researchers, policymakers, and industry leaders. Focused on innovation, accessibility, and collaboration, the summit provided a dynamic platform to address emerging technologies, infrastructure gaps, and policy advancements essential to transforming cancer care in India.

With cutting-edge breakthroughs in precision medicine, AI-driven diagnostics, biosimilars, and CAR-T cell therapy, the discussions underscored the need for a multi-stakeholder approach to ensure equitable cancer treatment for all.

A Call for Innovation & Collaboration

The summit opened with an inspiring keynote by Dr. Raj Bhandari, Member, National Technical Board of Nutrition and Health, NITI Aayog, emphasizing that India’s fight against cancer requires an integrated approach, blending research, technology, and healthcare reforms. He highlighted how data-driven innovations and AI-assisted diagnostics could revolutionize early detection and treatment strategies.

Following this, Dr. Sunil Kumar Khetarpal, Director, Association of Healthcare Providers (India), addressed the need to strengthen India’s cancer care ecosystem through public-private partnerships. He emphasized that affordable cancer treatment is possible only through infrastructure expansion, skilled workforce development, and sustained collaboration between healthcare and government bodies.

Key Sessions & Insights

Advancing Cancer Care: Strengthening Infrastructure & Workforce

This session explored how India can scale its oncology infrastructure to meet the rising burden of cancer cases. Experts stressed that a well-trained medical workforce, AI-enabled hospital operations, and improved accessibility would play a crucial role in delivering efficient care.

Biosimilars & Biologics: The Future of Affordable Cancer Treatment

Samir Desai, President & Head of Business Unit – Biologics and Vaccines, Zydus, highlighted how biosimilars can significantly lower the cost of cancer treatment. Discussions revolved around India’s potential to become a global leader in biosimilar manufacturing, ensuring wider access to advanced therapies at reduced costs.

CAR-T Cell Therapy: A Game Changer in Blood Cancer Treatment

A fireside chat with Prof. (Dr.) Vijay Patil, Medical Oncologist, Tata Memorial Hospital, provided insights into the transformative power of CAR-T cell therapy for leukemia and lymphoma. The conversation focused on:
✔ Reducing the high cost of CAR-T therapy through indigenous manufacturing
✔ The need for streamlined regulatory approvals and clinical trials
✔ Fostering global collaborations to drive affordability and accessibility

AI & Robotics in Cancer Care: The Next Frontier

In a compelling panel discussion, Dr. Sandeep Nayak, Chief of Surgical Oncology, MACS Clinic – Bangalore, outlined how AI and robotics are reshaping cancer diagnostics and treatment. The panel emphasized:
✔ AI-driven medical imaging for faster and more accurate diagnosis
✔ Robotic-assisted surgeries improving precision and patient recovery
✔ Ethical considerations in AI-driven decision-making

The Summit’s Impact & Takeaways

With over 500 delegates, the summit facilitated cross-industry networking, bringing together oncologists, AI specialists, biotech leaders, and policymakers to exchange ideas and explore partnerships. The event’s human-centric approach was further highlighted through the Tree of Hope initiative, where attendees shared messages of encouragement for cancer patients, reinforcing the importance of emotional resilience alongside medical treatment.

Key takeaways from the summit included:

✔ Accelerating AI adoption for early cancer detection and personalized treatment
✔ Expanding biosimilar production for affordable and accessible therapies
✔ Strengthening cancer care infrastructure and workforce training
✔ Enhancing policy frameworks for faster regulatory approvals

Looking Ahead: The Future of Cancer Care in India

The prestigous the Zydus Lifesciences presents ET Edge Onco Frontiers Summit 2025 powered by MOC India and co-powered by Eris Lifesciences in association with Association of Healthcare Providers (India) set the stage for transformative change in oncology. By fostering multi-stakeholder collaboration, technological innovation, and policy-driven solutions, the event reaffirmed the commitment to making cancer treatment more effective, accessible, and patient-centric.

As we move forward, a future shaped by AI, precision medicine, and strategic partnerships will not only redefine cancer care in India but bring hope to millions affected by the disease. The summit was not just an event—it was a catalyst for a healthcare revolution in oncology.

(DISCLAIMER: The information in this article does not necessarily reflect the views of The Global Hues. We make no representation or warranty of any kind, express or implied, regarding the accuracy, adequacy, validity, reliability, availability or completeness of any information in this article.)